RETRACTED: The clinical features and course of psoriatic arthritis in children
Abstract
The goal of this article is to provide an overview and comparison of published data on PsA with information obtained in the survey. A survey was conducted of 24 patients with PsA. Identified terms of formation of articular and cutaneous syndromes in PsA in children, as well as options for debut and height of the disease are presented. The brief characteristic of therapy is given. The data obtained svidedelstvuyut that for PsA in children was different: the debut changed the structure and height of the disease, the timing of the formation of cutaneous and articular syndrome, and this disease was more likely to suffer for young children.
About the Authors
S. N. Chebysheva
I.M. Sechenov First MSMU
Russian Federation
Russian Federation
PhD, associate prof. of the chair of childhood diseases
Moscow
A. V. Meleshkina
I.M. Sechenov First MSMU
Russian Federation
Russian Federation
PhD, assistant of the chair of childhood diseases
Moscow
E. S. Zholobova
I.M. Sechenov First MSMU
Russian Federation
Russian Federation
MD, prof. of the chair of pediatrics and pediatric rheumatology, prof. of the chair of childhood diseases
Moscow
N. A. Geppe
I.M. Sechenov First MSMU
Russian Federation
Russian Federation
Nataliya Anatolievna Geppe, MD, honoured doctor of Russia, director of the Research and educational clinical centre «Healthy Child», prof., head of the chair of childhood diseases
19 B. Pirogovskaya str., Moscow, 119435
Tel.: 8 (499) 248–64–79
References
1. Burdeiny A.P. Psoriatic arthritis: rheumatic diseases / Ed. by V.A. Nasonova, N.V. Bunchuk. M. Medicina, 1997. P. 314–324.
2. Bunchuk N.V. Psoriatic arthritis: rheumatology. National guide / Ed. By E.L. Nasonov, V.A. Nasonova. M. GEOTAR-MEDIA. 2008. P. 355–366.
3. Chebysheva S.N. Psoriatic arthritis: a guide to children's rheumatology / Ed. by N.A. Geppe, N.S. Podchernyaeva, G.A. Lyskina. M. GEOTAR-MEDIA. 2011. P. 285–299.
4. Badokin V.V. The prospects for using inhibitors TNF-α in psoriasis and psoriatic arthritis // Klin. pharmakologiya. 2005; 1: 76–79.
5. Moll J.M., Wright V. Psoriatic arthritis // Semin. Arthritis Rheum. 1973; 3: 55–78.
6. Southwood T.R. Psoriatic arthritis // Textbook of pediatric rheumatology. Toronto: W.B. Saunders Company. 2002. Р. 345–354.
7. Chebysheva S.N. et al. An experience in the use of infliximab in the treatment of adolescents with psoriatic arthritis: a difficult patient in the practice of pediatric rheumatologist / Ed. by N.A. Geppe, T.V. Ryabova. M.: Medicinskoe informacionnoe agentstvo. 2008. P. 275–281.
8. Antony C. et al. Successful treatment of severe psoriatic arthritis with infliximab // Arthritis Rheum. 1999; 42: 371.
9. Chebysheva S.N. et al. The blockers of tumor necrosis factor-α in psoriatic arthritis in children // Vrach. 2010; 1: 27–28.
Review
Views: 56
Email this article 